Pricing

Xenikos

7 people · 0 jobs

‌

Xenikos is developing a combination of two toxin-loaded anti-T-cell antibodies.

Industries

Therapeutics, Life Sciences

Employees

11-50

Links

Org chart

André de Lege

Controller & Accountant

Maria Marza Perez

CMC Project Manager

Jürgen van de Lagemaat

Director, Process Development & Commercialization

Board & advisors

Douglas E. Williams

Chairman

Francesco De Rubertis

Non-Executive Director

Jake Simson

Non-Executive Director

Teams

Leadership Team

2 people · 0 jobs

Offices

This company has no offices yet

Similar companies

Tango Therapeutics

3 followers

Science

6 followers

Cellares

4 followers

Amgen

296 followers

Pierre Fabre

17 followers

Revvity

10 followers

Kedrion Biopharma

19 followers

Novonesis

47 followers

Sanofi

310 followers

Gilead Sciences

164 followers

Regeneron

138 followers

Explore companies